PRELUDE THERAPEUTICS INC's ticker is PRLD and the CUSIP is 74065P101. A total of 63 filers reported holding PRELUDE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $160,000 | +28.0% | 24,180 | +0.7% | 0.06% | +39.1% |
| Q2 2022 | $125,000 | +38.9% | 24,005 | +84.0% | 0.05% | +15.0% |
| Q1 2022 | $90,000 | -47.7% | 13,048 | -5.6% | 0.04% | -38.5% |
| Q4 2021 | $172,000 | -12.7% | 13,815 | +119.6% | 0.06% | -25.3% |
| Q3 2021 | $197,000 | +3.7% | 6,292 | -5.0% | 0.09% | +11.5% |
| Q2 2021 | $190,000 | – | 6,622 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 10,039,691 | $124,994,000 | 1.61% |
| Baker Brothers Advisors | 10,123,824 | $126,042,000 | 0.61% |
| Pinz Capital Management, LP | 43,800 | $545,000 | 0.21% |
| HHLR ADVISORS, LTD. | 583,333 | $7,262,000 | 0.11% |
| Rock Springs Capital Management LP | 368,959 | $4,594,000 | 0.11% |
| Nan Fung Group Holdings Ltd | 20,350 | $253,000 | 0.08% |
| Virtus ETF Advisers LLC | 13,815 | $172,000 | 0.06% |
| PDT Partners, LLC | 35,907 | $447,000 | 0.03% |
| Jump Financial, LLC | 36,900 | $459,000 | 0.03% |
| Parkwood LLC | 12,667 | $158,000 | 0.03% |